The STS 58th Annual Meeting is quickly approaching, and we’re excited to connect with you. Here are some of the sessions presented in different tracks by STS. The STS 58th Annual Meeting will be live-streamed on a virtual meeting platform. We will be attending some of the scientific sessions organized by STS. Remember to register with STS to attend the virtual meeting to watch these sessions presented in different tracks, organized and planned by STS.
Meantime, connect with our sales team and explore some of our aortic-centric technologies.
STS Key Program Highlights
STS Key Program Highlights
From the Ascending to the Descending Aorta Session
The New Type A Arch Remodeling Stent for DeBakey I Acute Aortic Dissection: Results and Performance in 100 Implantations
Saturday, January 29, 2022 (12:54 PM – 1:06 PM)
Presented by: Matteo Montagner MD | German Heart Center Berlin
Adult Cardiac Top Abstract Session
PROACT Mitral: A Randomized Controlled Trial of Anticoagulation Regimen After On-X Mechanical Mitral Valve Replacement
Sunday, January 30, 2022 (11:12 AM – 11:27 AM)
Presented by: Michael W A Chu, MD FRCSC | Western University, London Health Sciences Centre
Disclaimer: The data for the Mitral arm of the PROACT clinical study is currently under FDA review. The On-X Mitral valve is not currently approved by the FDA for low INR of 2.0-2.5.
Note: All products and indications are not available/approved in all markets.
Clinical Trials
PERSEVERE
A Prospective, Single Arm, Multi-Center Clinical Investigation to Evaluate the Safety and Effectiveness of AMDS* in the Treatment of Acute Debakey Type I Dissection Pivotal IDE Study
PROACT Xa
Prospective Randomized Oral Anticoagulation Trial for Patients with an On-X Aortic Mechanical Valve – Factor Xa Inhibitor
PROACT Mitral
PROACT Mitral: Prospective Randomized On-X® Anticoagulation Clinical Trial
*Ascyrus Medical Dissection Stent Hybrid Prosthesis
Note: All products and indications are not available/approved in all markets.
Aortic-Centric Technologies
*Ascyrus Medical Dissection Stent Hybrid Prosthesis
Note: All products and indications are not available/approved in all markets.